市场调查报告书
商品编码
1518346
数位病理学市场:依产品、应用、最终用户划分 - 2030 年全球预测Digital Pathology Market by Offering (Hardware, Software, Service), Application (Diagnostic, Drug Discovery, Training), End User (Hospital, Academic Institute) - Global Forecast to 2030 |
数位病理市场预计到 2030 年将达到 18.6 亿美元,2023 年至 2030 年复合年增长率为 8.7%。
经过广泛的二次和初步研究以及对市场情景的详细分析,本报告提供了关键行业驱动因素、限制因素和市场驱动因素/课题的分析。
这一市场成长的推动因素包括慢性病盛行率的上升、扩大采用数位病理学解决方案以提高实验室效率以及数位病理诊断在伴随诊断和药物开发中的广泛应用。然而,数位病理检测服务缺乏报销限制了该市场的成长。
此外,对个人化医疗的需求不断增长、私人病理诊所推出价格实惠的扫瞄仪以及新兴经济体正在为数位病理解决方案提供者创造巨大的商机。然而,数位病理学的法律和监管障碍以及缺乏训练有素的病理学家是该市场的主要课题。
Digital Pathology Market Size, Share, Forecast, & Trends Analysis by Offering (Hardware [Scanner, Tissue Microarray], Software [Information Management, Image Analysis], Service), Application (Diagnostic, Drug Discovery), End User-Global Forecast to 2030
The digital pathology market is projected to reach $1.86 billion by 2030 at a CAGR of 8.7% from 2023 to 2030.
Succeeding extensive secondary and primary research and an in-depth analysis of the market scenario, the report provides an analysis of key industry drivers, restraints, opportunities, and challenges.
The growth of this market is driven by the rising prevalence of chronic diseases, the increasing adoption of digital pathology solutions to enhance lab efficiency, and the widening applications of digital pathology in companion diagnostics and drug development. However, the lack of reimbursements for digital pathology services restrains the growth of this market.
Furthermore, the rising demand for personalized medicine, the launch of affordable scanners for private pathology practices, and developing economies are generating significant opportunities for digital pathology solutions providers. However, the legal and regulatory hurdles in digital pathology and the shortage of trained pathologists are major challenges in this market.
The report offers a competitive landscape based on an extensive assessment of the product portfolios, geographic presence, and key strategic developments of leading market players during the last four years (2020-2023). The key players operating in the digital pathology market are 3DHISTECH Ltd. (Hungary), Leica Microsystems (a subsidiary of Danaher Corporation) (Germany), Hamamatsu Photonics K.K. (Japan), Nikon Corporation (Japan), Visiopharm A/S (Denmark), Koninklijke Philips N.V. (Netherlands), F. Hoffmann-La Roche Ltd (Switzerland), Glencoe Software, Inc. (U.S.), XIFIN, Inc. (U.S.), and PerkinElmer Inc. (U.S.).
Based on offering, in 2023, the hardware segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the increased demand for precise & accurate diagnosis and an increase in patients requiring in vitro tests.
Based on application, in 2023, the disease diagnosis segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the high burden of chronic diseases, the high adoption of teleconsulting, and rising awareness about the importance of early disease diagnosis.
Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the digital pathology market. The large market share of this segment is attributed to the increased availability and affordability of advanced technological pathology solutions at hospitals, the higher preference for hospitals/clinics as a primary center for care, and the high volume of patient inflow in hospitals & clinics.
An in-depth analysis of the geographical scenario in the digital pathology market provides detailed qualitative and quantitative insights into five major geographies (North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa) along with the coverage of major countries in each region. In 2023, North America is expected to account for the largest share of the digital pathology market. Furthermore, in 2023, the U.S. is expected to hold the major market share in North America. Market growth in the U.S. is driven by the digitization of pathology services, high investments in R&D, the high adoption of advanced technologies, and the increased demand for reliable and faster diagnostics.
Digital Pathology Market Assessment-by Offering
Note 1: Other hardware includes clinical microscopes and accessories.
Note 2: Other software includes digital storage systems, tissue microarray software, and telepathology platforms.
Digital Pathology Market Assessment-by Application
Digital Pathology Market Assessment-by End User
Digital Pathology Market Assessment-by Geography